InsidersTradesSigma
Track the AXIM BIOTECHNOLOGIES, INC. stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €1m. The latest transaction was filed on 15 October 2024 (Acquisition). Among the most active insiders: Valencia Catalina. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
AXIM BIOTECHNOLOGIES, INC. es una empresa enfocada en el desarrollo de productos biofarmacéuticos, particularmente para el manejo del dolor y enfermedades relacionadas con el cannabis. Cotiza en NASDAQ bajo el símbolo AXIM.